22:54 ETCadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026prnewswire·Apr 20 at 09:57 PMAKRO0.00%XBI+7.00%
16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?prnewswire·Apr 14 at 03:14 PMULY0.00%EQH+1.23%
23:28 ETAkeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L) 1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026prnewswire·Apr 6 at 10:32 PMBIS-0.78%LABU+0.27%
05:40 ETIvonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026prnewswire·Mar 31 at 04:42 AMSBIO+1.11%VHT+0.52%
22:05 ETAkeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistanceprnewswire·Mar 15 at 09:07 PMFBT-0.26%XBI+7.00%
Aker BioMarine Registers Share Capital Increase from Employee Share ProgramTip Ranks·Mar 12 at 11:34 AMBBH+0.25%ARKG-5.00%
21:59 ETACROBiosystems fördert Innovationen bei JPM Spotlight-Sessions von bioSeedin und unterstützt strategisch den Aufbau globaler Partnerschaftenprnewswire·Feb 11 at 09:00 PMBIB+0.73%ARKG-5.00%
Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt RestructuringGlobeNewswire·Jan 27 at 02:49 PMIBBQ+0.43%IBB+0.10%
Novo Nordisk’s Wegovy Pill And Akero Deal Reframe Obesity Growth StorySimplywall·Jan 25 at 02:35 AMAKRO0.00%NVO+1.85%
Top Mid Cap Stocks To Add to Your Watchlist - December 16thMarket Beat·Dec 16, 2025 at 02:42 PMAKRO0.00%APLD-3.00%
